Feasibility of using a transition diabetes team to commence injectable therapies postdischarge from a tertiary hospital: a pilot, randomised controlled trial.

ABSTRACT: OBJECTIVES:This study aimed to investigate if the use of a transition team was feasible for patients with diabetes being discharged from hospital on injectable diabetes therapies. DESIGN:Pilot, randomised controlled trial. SETTING:The trial was conducted between 2014 and 2016 conjointly by a tertiary referral hospital and a community healthcare provider. PARTICIPANTS:Hospital inpatients (n=105) on new injectable diabetes therapies were randomised 1:1 to transition team or standard care. The transition team received in-home diabetes education 24-48 hours postdischarge, with endocrinologist review 2-4 weeks and 16 weeks postdischarge. MAIN OUTCOME MEASURES:The primary outcome was feasibility, defined by percentage of patients successfully receiving the intervention. Secondary outcomes includ

SUBMITTER: Pyrlis F 

PROVIDER: S-EPMC6756454 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature